Company Directory

Company Directory

Company Directory - Infectious Disease Society of America

Company Details - Infectious Disease Society of America

Infectious Disease Society of America Logo

Infectious Disease Society of America

Website

A professional organization representing physicians and scientists specializing in infectious diseases, focused on improving the health of individuals and communities through advocacy, education, research, and evidence-based clinical guidelines.

CCI Score

CCI Score: Infectious Disease Society of America

44.94

-0.03%

Latest Event

IDSA Upholds Evidence-Based Safety of MMR Vaccine

Amid controversies over vaccine misinformation and leadership changes at the FDA, the Infectious Disease Society of America was cited by NBC News as affirming that no deaths have been linked to the MMR vaccine in healthy individuals. This reference underscores the IDSA’s commitment to promoting scientifically sound, evidence-based public health guidelines.

Take Action

So what can you do? Support IDSA by shopping, spreading the word, or offering your support.

Use Your Voice
OTHER TOOLS
Investigate
Share the Score
SUPPORT CCI

DISSENTER

Infectious Disease Society of America is currently rated as a Dissenter.

+25 to +44 CCI Score
These companies are vocal in their opposition to authoritarian regimes. They publicly criticize oppressive policies and engage in advocacy efforts to promote accountability and transparency, even if their actions aren’t as extensive as those of Moral Leaders.

Latest Events

  • IDSA Upholds Evidence-Based Safety of MMR Vaccine Logo
    MAR
    29
    2025

    Amid controversies over vaccine misinformation and leadership changes at the FDA, the Infectious Disease Society of America was cited by NBC News as affirming that no deaths have been linked to the MMR vaccine in healthy individuals. This reference underscores the IDSA’s commitment to promoting scientifically sound, evidence-based public health guidelines.

  • IDSA Lobbying Expenditure in 2023 Logo
    DEC
    31
    2023

    The Infectious Diseases Society of America spent $687,000 on lobbying efforts in 2023, as reported by OpenSecrets. This spending is associated with efforts around issues such as Medicare & Medicaid and indicates active political engagement in public health policy.

  • +50

    Political Contributions and Lobbying Efforts

    March 29

    IDSA’s lobbying expenditure demonstrates proactive engagement in the political process, likely aimed at advancing evidence-based public health policies. Such efforts are typically aligned with progressive, anti-authoritarian values by seeking to strengthen equitable access to healthcare, thereby countering policies that may undermine marginalized communities.

    Infectious Diseases Society of America Issues Lobbied • OpenSecrets

  • IDSA Recognizes Bipartisan Legislative Impact on Infectious Disease Policy Logo
    JUN
    15
    2023

    IDSA presented its '2023 Legislative Impact Awards' to a bipartisan group of U.S. senators and representatives for their crucial role in advancing legislation that boosts federal resources, strengthens the ID/HIV workforce, and enhances preparedness against infectious disease threats.

  • +65

    Executive Political Engagement

    March 29

    The awards recognize bipartisan legislative action that has successfully bolstered public health measures and improved support for infectious disease professionals. This kind of executive political engagement promotes policies that protect marginalized communities and enhances national readiness against health threats, aligning with anti-authoritarian values.

    IDSA Honors Senators, Representatives Making an Impact on ID

  • IDSA 2023 Lobbying Engagement Logo
    JAN
    01
    2023

    In 2023, the Infectious Diseases Society of America spent $120,000 on lobbying efforts, as reported by OpenSecrets. This spending reflects the organization’s active engagement in policy advocacy to promote evidence‐based public health measures.

  • +40

    Political Contributions and Lobbying Efforts

    March 29

    As a professional organization devoted to infectious disease research and advocacy, IDSA’s allocation of $120,000 for lobbying is indicative of a commitment to influencing public policy in support of science and public health. This type of political engagement is aligned with anti-fascist and progressive values, as it seeks to promote transparency and evidence-based decision making rather than partisan interests.

    Infectious Diseases Society of America Lobbying Profile • OpenSecrets

Industries

621111
Offices of Physicians (except Mental Health Specialists)
621511
Medical Laboratories
813920
Professional Organizations